Day 1 - Friday, November 22
Meeting category
Date(s)
22 Nov 2019 - 23 Nov 2019
Location
Amsterdam,
Netherlands
Organizer
Titanium Level Support
Sponsor logos
International Viral Hepatitis Elimination Meeting (IVHEM) 2019
Related Enduring Materials
Enduring Materials
Downloads:
Opening Session -
Chairs
Margaret Hellard, AM, MBBS, FRACP, FAFPHM, PhD
Burnet Institute, Australia
13:00 CEST
Opening of the Meeting
13:20 CEST
Introduction of Simplification
13:35 CEST
WHA / Community Perspective on the Need for Simplification
13:50 CEST
WHO / Perspective on the Simplification Strategies
Session 1: Prevention -
John Ward, MD
Chair
14:15 CEST
Introductory Lecture
Coalition for Global Hepatitis Elimination, Task Force for Global Health / Rollins School of Public Health, Emory University, United States
14:40 CEST
Canada’s Experience with Needle Exchange Programs
Session 2: Monitoring and Testing -
Chair
Manal El-Sayed, MD
Ain Shams University, Cairo, Egypt
16:15 CEST
Introductory Lecture
16:30 CEST
Egypt’s Experience with Mass Monitoring and Testing Program
16:45 CEST
Uganda’s Experience
Abstract-driven Presentations - 17:30
17:30 CEST
Use of the HBV Viral Load Medical Prescription as a Preliminary Assessment of HBV Infection Burden in New Caledonia: a 2014-2019 Retrospective Study
17:35 CEST
Overview of the National Hepatitis B Viral Load Testing Programme in Uganda
V. Kasone
#3
17:40 CEST
Alabama’s HCV Linkage and Retention in Care Outcomes in Community Settings
A. Lee
#5
17:45 CEST
Mortality from Liver Diseases Associated with Hepatitis B and C in the EU/EEA – Descriptive Analysis and Estimation of 2015 Baseline
17:50 CEST
The Uptake of an Innovative Approach to Reduce HCV Transmission among MSM: the NoMoreC Project
17:55 CEST
Emergency Department Screening: Strategy for Elimination through an Innovative HBV and HCV Screening, Care, and Cure Program
Day 2 - Saturday, November 23
Session 3: Model for Care - Focus on HBV -
Chair
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease
08:30 CEST
Introductory Lecture
08:45 CEST
Rwanda’s Model for Care
09:00 CEST
Ethiopia’s Model for Care
Abstract-driven Presentations - 09:45
09:45 CEST
Changes of the Composition of the Hepatitis B Virus (HBV) surface Antigen (HBsAg) are Associated with HBsAg Loss during Nucleos(tid)e Analogues and Peg-interferon-alfa2a Treatment
09:50 CEST
Enhancing the Hepatitis B Care Cascade in Australia: a Cost-Effectiveness Model
M. Hellard
#10
Session 4: Model for Care - Focus on HCV -
Chair
Margaret Hellard, MBBS, FRACP, FAFPHM, PhD
Burnet Institute, Australia
10:45 CEST
Introductory Lecture
10:55 CEST
Mongolia’s Model for Care
11:05 CEST
India’s Model for Care
11:15 CEST
Pakistan’s Model for Care
11:25 CEST
Panel Discussion - Key Controversies
Abstract-driven Presentations - 11:55
11:55 CEST
Evaluation of the Hepatitis C Care Cascade in the Country of Georgia: Monitoring Progress towards Elimination
12:00 CEST
Strategies towards Elimination of Hepatitis C in Iceland: Models of Care for the Treatment as Prevention for Hepatitis C (TraP HeP C) Program
12:05 CEST
Micro-Elimination of Hepatitis C amongst People Living with HIV (PLHIV) in Punjab, India
12:10 CEST
Integration of Hepatitis C Treatment Services with Harm Reduction Service Centers for People who Inject Drugs in Kenya: Experience from Test and Link to Care for Injecting Drug Users Study
12:15 CEST
Finding the Missing Millions: Lessons Learned from Community Outreach Program in Rural Communities
G. Shiha
#16
12:20 CEST
Towards the Elimination of HCV in British Columbia: A strategy to Address the “messy middle”
Abstract-driven Presentations - 13:40
13:40 CEST
Real-World Challenges to and Opportunities for Microelimination in Two Remote Communities in Northwestern Ontario
13:45 CEST
Policy Implementation Index Based off of Patient Reported Outcomes: The Hep-CORE Study
13:50 CEST
Hepatitis C Elimination in the Netherlands (CELINE): a Nationwide Study Retrieving Lost to Follow-Up Chronic Hepatitis C Patients
13:55 CEST
Oral Prescription Opioid Use should be Considered a Risk Factor for HCV Infection: Another Step Toward HCV Elimination
Session 5: Innovations for Simplification - Panel Discussion - 14:15
14:15 CEST
Faculty
Jordan Feld, MD, MPH
Toronto Centre for Liver Disease / University Health Network, Canada
Michael Ninburg
Hepatitis Education Project, USA
Margaret Hellard, MBBS, FRACP, FAFPHM, PhD
Burnet Institute, Australia
Manal El-Sayed, MD, PhD
Ain Shams University, Egypt
Sunil Solomon, MBBS, MPH, PhD
Johns Hopkins Medicine, USA
Jean Damascene Makuza, MD
Rwanda Biomedical Center, Rwanda
15:45 CEST
End of the Workshop
Overview
Welcome
Over 80 participants attended the 6th edition of the International Viral Hepatitis Elimination Meeting, which took place on 22-23 November 2019 in Amsterdam, The Netherlands. The Organizing Committee would like to thank all the invited speakers and participants for their contribution to this meeting!
We are grateful to our supporter Gilead Sciences for making this event possible.
IVHEM is a global forum for the exchange of practical experiences for translating diagnostic and therapy advances of viral hepatitis into broad applications that accelerate progress toward elimination of viral hepatitis as a public health threat by 2030.
Support
Titanium Level
Endorsers
The International Viral Hepatitis Elimination Meeting (IVHEM) 2019 was endorsed by the following societies and organizations.
Language
Related Programs
